Symptoms: Aromatase Inhibitor Induced Arthralgias-Reference-Cited by-同舟云学术

Symptoms: Aromatase Inhibitor Induced Arthralgias

Published:2015 Issue: Volume: Page:89-100
ISSN:0065-2598
Container-title:Improving Outcomes for Breast Cancer Survivors
language:
Short-container-title:

Author:

Hershman Dawn L.,Loprinzi Charles,Schneider Bryan P.

Publisher

Springer International Publishing

Link

http://link.springer.com/content/pdf/10.1007/978-3-319-16366-6_7

Reference57 articles.

1. Anonymous (1998) NIH consensus conference. Acupuncture. JAMA 280:1518–1524

2. Azria D, Lamy Y, Belkacemi G et al (2007) Letrozole-induced arthralgia: results of a multicenteric prospective trial exploring clinical parameters and plasma biomarkers. ASCO Breast Cancer Symposium

3. Baum M, Budzar AU, Cuzick J (2002) Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial. Lancet 359:2131–2139 [see comment][erratum appears in Lancet 2002 Nov 9;360(9344):1520]

4. Birrell S, Tilley W (2009) Testosterone undecanoate treatment reduces joint morbidities induced by anastrozole therapy in postmenopausal women with breast cancer: results of a double-blind, randomized phase II trial. San Antonio breast cancer symposium

5. Blanchard O, Tsagris L, Rappaport R et al (1991) Age-dependent responsiveness of rabbit and human cartilage cells to sex steroids in vitro. J Steroid Biochem Mol Biol 40:711–716

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of Aromatase Inhibitor-Induced Musculoskeletal Symptoms with Central Sensitization-Related Symptoms: A Cross-Sectional Study;Breast Care;2024

2. COMT Val158Met Affects the Analgesic Response to Acupuncture Among Cancer Survivors With Chronic Pain;The Journal of Pain;2023-09

3. Impact of hormone therapy side effects on health-related quality of life, distress, and well-being of breast cancer survivors;Scientific Reports;2022-11-04

4. Androstenedione and Follicle-Stimulating Hormone Concentration Predict the Progression of Frailty Syndrome at One Year Follow-Up in Patients with Localized Breast Cancer Treated with Aromatase Inhibitors;Biomedicines;2022-07-07

5. Systemic therapies for preventing or treating aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer;Cochrane Database of Systematic Reviews;2022-01-10